KYMR Earnings

Quarterly EPS
$-0.82
Q3 2024
$-0.88
Q4 2024
$-0.82
Q1 2025
$-0.95
Q2 2025
$-0.94
Q3 2025
$-0.97
Q4 2025
$-0.71
Q1 2026
$-0.62
Q2 2026
Latest Revenue65.0M
Latest Net Income-61211000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.6265.0M-61211000+466.4%+34.7%
Q1 2026-$0.7134.4M-69234000+55.5%+13.4%
Q4 2025-$0.972.9M-86981000-61.2%-10.2%
Q3 2025-$0.942.8M-82175000-26.1%-14.6%
Q2 2025-$0.9511.5M-76614000-55.3%-63.8%
Q1 2025-$0.8222.1M-65581000+114.8%-18.8%
Q4 2024-$0.887.4M-70752000-84.6%-252.0%
Q3 2024-$0.823.7M-62487000-20.9%+8.9%
Q2 2024-$0.5825.6M-42062000
Q1 2024-$0.6910.3M-48557000
Q4 2023-$0.2547.9M-14368000
Q3 2023-$0.904.7M-52867000
Kymera Therapeutics (KYMR) — Earnings